 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
2002Budson AE, Sullivan AL, Mayer E, Daffner KR, Black PM, Schacter DL. Suppression of false recognition in Alzheimer's disease and in patients with frontal lobe lesions. Brain 2002; 125:2750-2765. [PDF] Friedland RP, Petot GJ, Farrer LA. Alzheimer’s disease and diet. Arch Journal of Psychiatry 2002; 13:10-17. Graff-Radford NR, Green, RC, Go RCP, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA. Association between apolipoprotein e genotype and Alzheimer disease in African American subjects. Archives of Neurology 2002; 59:594-600. [PDF] Green RC. Risk assessment for Alzheimer’s disease with genetic susceptibility testing: has the moment arrived? Alzheimer’s Care Quarterly 2002; 3:208-214. [PDF] Green RC, Cupples LA, Go R, Benke KS, Edeki T, Griffith PA, Williams M, Hipps Y, Graff-Radford N, Bachman D, Farrer LA. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 2002; 287:329-336. [PDF] Hurley AC, Volicer L. Alzheimer disease: It’s okay, mama, if you want to go, it’s okay. JAMA 2002; 288:2324-2331. [PDF] Riazanskaya N, Lukiw WJ, Grigorenko A, Korovaitseva G, Dvoryanchikov G, Moliaka Y, Nicolaou M, Farrer L, Bazan NG, Rogaev E. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. Molecular Psychiatry 2002; 7:891-898. [PDF] Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PWF, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. New England Journal of Medicine 2002; 346:476-483. [PDF] Yaar M, Zhai S, Fine RE, Eisenhauer PB, Arble BL, Steward KB, Gilchrest BA. Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. Journal of Biological Chemistry 2002; 277:7720-7725. [PDF] |
|
 |
 |
 |
 |
 |
|